141 filings
Page 4 of 8
6-K
OPT
Opthea Limited
10 Nov 22
Opthea to Present at Jefferies London Healthcare Conference
4:17pm
6-K
OPT
Opthea Limited
24 Oct 22
Current report (foreign)
6:01am
20-F
2022 FY
OPT
Opthea Limited
Annual report (foreign)
29 Sep 22
11:09am
6-K
OPT
Opthea Limited
26 Sep 22
Market Announcements Office
4:15pm
6-K
OPT
Opthea Limited
30 Aug 22
Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights
7:02am
6-K
OPT
Opthea Limited
26 Aug 22
Notice of Extraordinary General Meeting and Explanatory Notes
4:31pm
6-K
OPT
Opthea Limited
25 Aug 22
Current report (foreign)
4:30pm
6-K
OPT
Opthea Limited
15 Aug 22
Opthea Secures up to US$170 Million in Non-Dilutive Financing for OPT-302 in wet AMD
6:08am
6-K
OPT
Opthea Limited
11 May 22
Opthea To Present at Upcoming Investor Conferences
6:03am
6-K
OPT
Opthea Limited
10 May 22
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
5 May 22
Opthea Data for OPT-302 in Combination with Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) Presented at ARVO 2022
6:02am
6-K
OPT
Opthea Limited
29 Apr 22
Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
6:03am
6-K
OPT
Opthea Limited
22 Apr 22
Current report (foreign)
7:01am
6-K
OPT
Opthea Limited
22 Apr 22
Current report (foreign)
7:00am
6-K
OPT
Opthea Limited
22 Apr 22
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
30 Mar 22
Index to Condensed Consolidated Financial Statements
5:18pm
6-K
OPT
Opthea Limited
10 Mar 22
Opthea To Present at Oppenheimer’s 32nd Annual Healthcare Conference
4:15pm
6-K
OPT
Opthea Limited
2 Mar 22
Current report (foreign)
4:16pm
6-K
OPT
Opthea Limited
28 Feb 22
Current report (foreign)
6:10am
EFFECT
OPT
Opthea Limited
28 Feb 22
Notice of effectiveness
12:15am